Structure-Function Relationships in OxlT, the Oxalate/Formate Transporter of Oxalobacter formigenes
TOPOLOGICAL FEATURES OF TRANSMEMBRANE HELIX 11 AS VISUALIZED BY SITE-DIRECTED FLUORESCENT LABELING*

DaXiong FuDagger and Peter C. Maloney§

From the Department of Physiology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Analysis of hydropathy suggests that in OxlT, the oxalate/formate antiporter of Oxalobacter formigenes, lysine 355 is within transmembrane helix no. 11. To test this idea, we used single-cysteine, histidine-tagged OxlT variants to study the organization of a 30-residue segment (residues 344-373) containing this region. Topology was examined by probing the A345C and A370C proteins with Oregon Green maleimide carboxylic acid, an impermeant and fluorescent thiol-reactive agent. Examination of purified protein showed that only A370C was fluorescent after treating intact cells with the probe, while both proteins were modified in tests with isolated membrane ghosts. In addition, labeling of A370C, but not A345C, was blocked when external cysteines were protected with the impermeant and nonfluorescent agent, methanethiosulfonate ethyltrimethylammonium. These findings confirm that A345 faces the cytoplasm, while A370C faces the periplasm. A similar study focused on 13 single-cysteine variants positioned throughout the target segment. That work revealed a striking discontinuity in reactivity toward Oregon Green maleimide; cysteines within a 10-residue central core (residues 351-360) were not labeled when membranes were probed, but were readily modified after protein denaturation. We suggest this core resides within the lipid bilayer, unavailable to an impermeant reporter. Since this region includes position 355, we also suggest that lysine 355 lies within the OxlT hydrophobic sector, where it may facilitate the binding and translocation of the anionic substrates, oxalate and formate.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Solute transporters comprise a large, broadly homologous collection of membrane proteins that catalyze the transmembrane passage of impermeable substrates (1-4). Despite their numbers, however, only a few models are available for study at the level of biochemistry and biophysics. One such model is the transporter, OxlT (5, 6), a newly recognized member of the major facilitator superfamily (7), which functions as an anion exchange carrier during the one-for-one antiport of divalent oxalate and monovalent formate in the Gram-negative anaerobe, Oxalobacter formigenes (8). This electrogenic exchange, in combination with consumption of a single internal proton during oxalate decarboxylation, functions as a virtual proton pump, enabling this cell to generate ATP by decarboxylative phosphorylation (3, 8, 9). Theoretical considerations (5, 8, 9), and the finding of OxlT variants during genomic sequencing of Archaeoglobus fulgidis (10), suggest that added biochemical study of OxlT can be of value to the ongoing investigation of membrane transport.

Hydropathy analysis of the OxlT amino acid sequence suggests the presence of 12 hydrophobic segments (11), and circular dichroism spectroscopy of purified, solubilized OxlT supports the idea that these segments are structured as membrane-spanning alpha -helices (6). A closer examination of the putative OxlT topology reveals an unexpected feature, however; the hydrophobic sector appears to contain a single charged residue, a lysine (Lys355) positioned near the center of transmembrane helix 11 (TM11)1 (11). This is counterintuitive, since placement of an uncompensated charge within a hydrophobic environment can significantly destabilize a membrane protein (12, 13). On the other hand, the location of Lys355 might be rationalized if such an energetic disadvantage contributed an electrostatic component utilized in the process of transport. This idea is all the more attractive because OxlT must capture and translocate anions (oxalate and formate), implying direct interaction between the negatively charged substrate and unidentified positive element(s) within a translocation pathway. In this latter circumstance, Lys355 becomes a likely candidate.

Such an argument depends heavily on one interpretation of hydropathy, and it is essential to have positive experimental evidence that confirms or rejects this view before embarking on any extended study. The work reported here was designed to address this specific issue by answering two questions. (i) Does the segment containing Lys355 actually span the plasma membrane? (ii) Where within this interval does Lys355 reside, relative to the internal and external aqueous phases? As a tool to answer these questions, we generated a panel of single-cysteine mutants spanning the entirety of TM11, so that the environment at each position could be probed with a membrane-impermeable fluorescent reporter, OGM. Use of this approach allowed us to confirm the postulated topology in this region and to identify a set of 10 contiguous residues (residues 351-360) that form an inaccessible core within TM11, thereby defining the location of Lys355 as at the center of the OxlT hydrophobic sector.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Mutagenesis and Protein Expression-- OxlT, encoded within pBluescript II SK+ (Ampr), carried a C-terminal extension of nine tandem histidine residues to facilitate protein purification (6). Oligonucleotide-directed mutagenesis (ChameleonTM, Stratagene) was used to replace the two endogenous cysteines, and the C28G/C271A, cysteine-less variant served as parent to 30 single-cysteine derivatives constructed at positions 344 through 373. All mutants were confirmed by DNA sequencing (14).

To suppress uninduced protein expression, plasmids specifying OxlT were carried together with pMS421 (Specr, LacIq) (11). After co-transformation of Escherichia coli XL-1 cells, one or a few colonies were inoculated into 1 ml of LB broth (plus antibiotics) and grown at 37 °C overnight with vigorous shaking. These cells were subcultured in 50 ml of LB broth (plus antibiotics) and grown for 1-2 h until the exponential phase (A600 of 0.2), at which point isopropyl-1-thio-beta -D-galactopyranoside was added to 1 mM. Growth continued for an additional 4 h before cells were harvested.

Thiol-specific Fluorescent Labeling-- Site-specific fluorescent labeling was designed to selectively attack either cysteines exposed to the extracellular medium or cysteines exposed at the intracellular surface. We also performed labeling to identify cysteines exposed to an aqueous phase, without regard for their normal disposition.

To label cysteines exposed at the extracellular surface, intact cells were harvested by centrifugation (4,000 g × 2 min) and resuspended at moderate density (A600 of 1) in Buffer A (100 mM potassium sulfate, 50 mM potassium phosphate, pH 8.0) to which was added 40 µM freshly prepared OGM. After a 20-min incubation at 23 °C, the labeling reaction was quenched by addition of 2 mM beta -mercaptoethanol, followed immediately by three cycles of centrifugation and washing using Buffer A alone. Labeled cells were then resuspended in 20 ml of lysis solution (300 µg/ml lysozyme, 40 µg/ml DNase, 5 mM EDTA, and 10 mM Tris/HCl, pH 7.5), and incubated at room temperature for 10-15 min to initiate cell rupture (15). Membrane ghosts were obtained by 10-fold dilution in distilled water, and cytoplasmic proteins were removed by three cycles of centrifugation (6,000 g × 10 min) and resuspension in distilled water (15). These membranes served as the source of OxlT for solubilization and purification (below).

Cysteines exposed at the intracellular surface were identified by a two-step protocol. External cysteines were blocked by an initial 5-min preincubation of cells in Buffer A containing (freshly dissolved) 200 µM MTSET, a nonfluorescent, membrane-impermeable thiol-specific reagent. MTSET was removed by three cycles of centrifugation and washing using Buffer B (100 mM potassium sulfate, 50 mM MOPS/K, pH 7), without mercaptoethanol, and preblocked cells were used for preparation of membrane ghosts, as above. This exposed unmodified cysteines which had faced the cytoplasm, and these were labeled by incubating membrane ghosts for 20 min in Buffer C (20 mM potassium phosphate, pH 8) containing 40 µM OGM; the reaction was quenched with 2 mM beta -mercaptoethanol, followed immediately by three cycles of centrifugation and resuspension, using distilled water, and by protein solubilization and OxlT purification (below).

To simultaneously label cysteines exposed at both surfaces, membrane ghosts were prepared directly, without blocking external cysteines, and incubated for 20 min in Buffer C with 40 µM OGM before quenching the reaction as above.

OxlT Purification-- Protein was solubilized by resuspending membrane ghosts in 5 ml of solubilization buffer (20 mM MOPS/K, 20% (v/v) glycerol, 0.42% (w/v) E. coli phospholipid, 6 mM beta -mercaptoethanol, 10 mM potassium oxalate, and 1.5% (w/v) octyl-beta -D-glucopyranoside). After incubation at 4 °C for 1-2 h on a rotary platform, insoluble debris was removed by centrifugation in the cold (6,000 g × 30 min), and OxlT was purified in a one-step affinity procedure (6). In brief, the polyhistidine C-terminal tail was used to immobilize OxlT in 100 µl of Ni-nitrilotriacetic acid resin by an overnight batch incubation in the cold on a rotary platform shaker. The resin, with bound OxlT, was then packed into a Micro Bio-Spin chromatography column (Bio-Rad) and washed on ice with a total of 3 ml of wash buffer (solubilization buffer supplemented with 200 mM sodium fluoride and 50 mM imidazole). Elution of OxlT was achieved by a brief centrifugation in the cold using 100 µl of 50 mM Tris/HCl, 2% SDS, 10% glycerol, 0.5 M imidazole, pH 7.

SDS-PAGE-- Protein (1-2 µg/lane) was subjected to SDS-PAGE using a 12% polyacrylamide gel matrix. After electrophoresis, the gel was rinsed briefly with a destaining solution (10% glacial acetic acid, 15% methanol), and fluorescent profiles were recorded with a Molecular Dynamics STORM fluorescence imaging system (blue fluorescent-chemifluorescence mode, excitation wavelength of 450 ± 30 nm, photomultiplier voltage of 900 mV, pixel size of 100 µm). After recording a fluorescence profile, the protein content of each lane was evaluated by staining the same gel with Coomassie Brilliant Blue. The Coomassie-stained profile was recorded on film and digitized using a UMax PowerLook scanner.

Immunoblot Analysis-- Detergent extracts of membrane ghosts (0.35 mg of protein/ml) were analyzed by SDS-PAGE. Each of three gels contained samples (1.75 µg of protein/lane) of 10 single-cysteine mutants and the cysteine-less parent. After electrophoresis, proteins were transferred to nitrocellulose and probed with a rabbit polyclonal antibody directed against the OxlT N terminus (11). OxlT expression was detected by chemiluminescence, and signals were quantitated using NIH Image v1.59. Expression of each OxlT variant was normalized to that of the cysteine-less parental control found on the same gel.

Assay of Oxalate Transport-- To determine the specific activity of single-cysteine OxlT mutants, a sample (14 µg of protein) of the detergent extract (above) was used for reconstitution into proteoliposomes loaded with 100 mM potassium oxalate, as described previously (6, 11). [14C]Oxalate transport was measured by an abbreviated assay (10, 12) that was terminated after steady state was reached (10 min) (11). Oxalate transport by each mutant was normalized to that of the cysteine-less parental protein, and specific activity relative to the parent was calculated by correction for protein expression as assessed by immunoblot analysis of the same sample (above).

Other Assays-- Protein was measured by the method of Schaffner and Weissman (16), using bovine serum albumin as a standard.

Chemicals-- [14C]Oxalate was from NEN Life Science Products, OGM and MTSET were purchased from Molecular Probes Inc., and octyl-beta -D-glucopyranoside was from Boeheringer-Calbiochem Corp. E. coli phospholipid was purchased from Avanti Polar Lipids, Inc.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Characterization of OxlT Single-cysteine Variants-- To construct single-cysteine OxlT variants, we first removed the two endogenous cysteine residues by site-directed mutagenesis. In work using another bacterial transporter, UhpT, substitution of cysteine with serine generated a cysteine-less variant whose activity was reduced by 60% relative to the wild type (17). For this reason, we replaced OxlT cysteines with residues more commonly found in membrane proteins, so that cysteine at position 28 was changed to glycine, while cysteine at position 271 was replaced by alanine. This gave a cysteine-less (C28G/C271A) derivative whose expression and activity levels were nearly identical (90%) to that of wild type OxlT. We next used this derivative as a template for construction of 30 new variants, each containing a single cysteine, throughout the region (residues 344-373) expected to contain transmembrane helix 11.

Immunoblot analysis of this panel (Fig. 1, left) indicated that with the exception of the N347C, A368C, and I369C derivatives, for which no detectable protein was found, most variants were expressed in membranes at levels comparable to that of the cysteine-less parent. Each of three independent experiments gave similar estimates of protein expression, with individual variants scored at levels ranging from 30 to 230% of the cysteine-less parent (Fig. 1, right). Since the parental (and wild type) proteins are present at 3-5% of total membrane protein in both O. formigenes (5) and E. coli (11) we expected that most of the single-cysteine mutants could be purified in microgram quantities from a few milliliters of culture, a yield sufficient for the anticipated fluorescent labeling experiments (below).


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 1.   Expression of single-cysteine variants. Left, Western blots of OxlT single-cysteine variants. Samples from crude detergent extracts of membrane ghosts were subjected to SDS-PAGE (1.75 µg of protein/lane), transferred to nitrocellulose, and probed with an OxlT-specific polyclonal antibody (see "Experimental Procedures"). Antibody binding was visualized by chemiluminescence. Right, summary of three independent experiments (as in part A) to evaluate expression of OxlT single-cysteine variants. Expression is given relative to that of the cysteine-less parent (±S.D.).

The functional analysis of these single-cysteine variants used measurement of the oxalate self-exchange reaction (8) in oxalate-loaded proteoliposomes. These assays indicated a broad range of capacities (Fig. 2); about two-thirds of the mutants (21/30) had a specific activity comparable to that of the cysteine-less parent (>= 30%); a minority (5/30) had reduced activity relative to the parent (2-20%), while in four cases there was no detectable oxalate transport. This last group included the N347C, A368C, and I369C variants, as expected from their reduced levels of expression (Fig. 1). We noted that the K355C variant, despite its normal level of expression (Fig. 1), failed to exhibit oxalate transport, suggesting a significant functional role for this charged residue.


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 2.   Specific activities of OxlT single-cysteine variants. For each single-cysteine variant, an equal amount of protein was used for reconstitution in oxalate-loaded proteoliposomes. The graph shows incorporation of [14C]oxalate as measured in three different experiments, relative to that of the cysteine-less parent (±S.D.), corrected for protein expression (Fig. 1). The solid line is drawn at the 30% mark; targets used in analyzing topology (see Fig. 4) had >= 30% parental specific activity

Orientation of TM11-- Hydropathy analysis of the OxlT amino acid sequence suggests the presence of 12 transmembrane segments (TM1-TM12) and that Lys355 may lie within TM11 (11). The peak hydropathy in the area surrounding TM11 only marginally exceeds the usual criterion for a transmembrane structure (12, 13), so our initial experiments were designed to establish whether this region actually traverses the membrane. This was accomplished by examining the accessibility to a membrane-impermeable, thiol-specific fluorescent probe (OGM) of single-cysteine targets predicted to be at either the extracellular or intracellular surface. Labeling of cysteine exposed to the external phase was achieved by direct exposure of intact cells to the probe, while labeling of cysteine exposed at the internal surface was performed by a general attack using isolated membranes, after external targets were protected by a nonfluorescent blocking agent (MTSET).

These initial experiments utilized two single-cysteine variants, A345C and A370C, whose high levels of expression (Fig. 1) and activity (Fig. 2) ensured an overall structure closely resembling authentic OxlT. In preliminary work, we considered both tetramethylmaleimiderhodamine and OGM as candidate probes. The latter proved far superior, and only OGM showed a side-specific reactivity consistent with an impermeant character. We attribute this differential behavior to either or both of two factors. First, the OGM carboxyl and hydroxyl groups have pKa values <5, while the single carboxyl of tetramethylmaleimiderhodamine has a pK near neutral pH (pK = 6.8); thus, only OGM was fully deprotonated under our conditions of labeling (pH 8). Second, it seemed feasible that the rhodamine-linked probe could be rendered permeable by formation of an internal salt bridge between its anionic and cationic groups.

This preliminary work indicated OGM was suitable for our purposes, a conclusion validated by the topological mapping of cysteines at positions 345 and 370. Thus, after intact cells were directly exposed to OGM, both the A345C and A370C proteins could be readily purified, but only the latter contained the fluorescent label (Fig. 3, experiment 1). In contrast, when extracellular cysteines were first blocked by the nonfluorescent MTSET, subsequent exposure of isolated membranes to OGM yielded fluorescent labeling of only the A345C protein (Fig. 3, experiment 2). Moreover, under these latter conditions we could show equally efficient labeling of the external cysteine, provided the preblock with MTSET was omitted (Fig. 3, experiment 3). We also labeled membranes in the presence of 100 mM potassium oxalate, but use of excess substrate (and high ionic strength) had no effect on labeling of the A345C and A370C proteins (not shown; other conditions as in Fig. 3, experiment 3). Two conclusions follow from these findings. First, it is clear that positions 345 and 370 are on opposite membrane surfaces, with the former facing the cytoplasm and the latter exposed to the external medium. This confirms the general topology derived from the original analysis of hydropathy in this region (11) and verifies the existence of TM11. Second, perhaps more important, these experiments may form the basis of a general method for determining topology by site-directed fluorescent labeling.


View larger version (73K):
[in this window]
[in a new window]
 
Fig. 3.   Positions 345 and 370 lie on opposite membrane surfaces. Bottom drawings indicate the predicted OGM accessibility of proteins A345C and A370C as analyzed in three experimental conditions. SDS-PAGE of purified protein was used to monitor fluorescence labeling patterns (top right), while OxlT content was revealed by staining the same gel with Coomassie Blue (top left). In experiment 1, intact cells were exposed to OGM before a quench by beta -mercaptoethanol, cell lysis and preparation of membrane ghosts. In experiment 2, external cysteines were blocked by preincubation with MTSET, which was removed prior to preparation of membrane ghosts and OGM labeling of the newly exposed internal cysteines. In experiment 3, direct labeling of membrane ghosts with OGM allowed detection of cysteines exposed to both internal and external phases.

Definition of a TM11 Hydrophobic Core Surrounding Lys355-- The main goal of these experiments was to test the idea that Lys355 is located within the OxlT hydrophobic core. If so, it seemed unlikely that hydrophilic probes such as OGM and MTSET could be used to label the single-cysteine K355C variant. If, on the other hand, such reactivity were found, the null phenotype of this variant (Fig. 2) would not support any simple interpretation. To avoid such ambiguity, we chose to evaluate the topology of TM11 by studying single-cysteine variants of normal specific activity (>= 30% parental level). In this way, the location of Lys355 could be inferred from the locations of its neighbors.

With this strategy in mind, we selected 13 single-cysteine variants, each of robust activity, as representative of TM11. For each protein, the accessibility of its cysteine to OGM was determined by the generalized labeling of membrane ghosts obtained after cell lysis, using conditions which had enabled labeling of both external and internal positions (Fig. 3, experiment 3). In principle, because such labeling took place with OxlT embedded within the membrane, this allowed identification of cysteines normally exposed to the internal or external aqueous phases, but not of cysteines at positions within the lipid bilayer. Indeed, an examination of the fluorescence profile obtained in such an experiment (Fig. 4, bottom panel) revealed a discrete pattern of reactivity to OGM according to the location of cysteine within the target interval. Significant fluorescent signals were found at positions 345, 346, 348, and 350; little or no labeling could be detected at positions 351, 353, 356, 357, and 360; while fluorescent signals reappeared at the more distal positions, 361, 364, 367, and 370. This differential response was not attributable to differences in protein content, since Coomassie staining of the same gel showed comparable levels of protein in all lanes (Fig. 4, top panel). Nor did this pattern reflect variability in the cysteine content of these variants, since each could be labeled in the parallel control when OGM addition was delayed until protein had been denatured by SDS (Fig. 4, middle panel). In that case, only the cysteine-less parent failed to take up the fluorescent probe. Such controls indicate that any differential labeling by OGM reflects the relative accessibility of the individual cysteines, and since this occurred only when the proteins were labeled in situ, it seemed most likely that the unreactive positions (residues 351-360) lie within the hydrophobic core of OxlT, at the center of TM11.


View larger version (97K):
[in this window]
[in a new window]
 
Fig. 4.   The TM11 core is inaccessible to Oregon Green maleimide. The hydrophobic core of TM11 was defined experimentally by OGM labeling of the indicated single-cysteine variants spanning the whole of the transmembrane segment. Membrane ghosts of each variant were exposed to OGM as described (see "Experimental Procedures"), prior to protein solubilization, purification and analysis using SDS-PAGE. A single gel containing all samples was used to record the fluorescence signal (bottom panel) before staining with Coomassie Blue to visualize protein (top panel). Duplicate samples (middle panel) were exposed to OGM after protein denaturation by addition of excess (1 mM) probe to the 2% SDS sample buffer about 15 min prior to PAGE. The amino acid sequence of the target region (residues 344-370) is given below the bottom panel; Lys355 is noted by an arrow.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The work described here has focused on a 30-residue segment (residues 344-373) in the anion exchange transporter, OxlT. In particular, we sought to confirm or reject the idea of a transmembrane segment in this region and to determine whether a basic residue in the center of this segment (Lys355) is within the OxlT hydrophobic sector, where the presence of a resident positive charge might influence substrate binding and translocation. To address these issues, we exploited affinity purification of histidine-tagged OxlT (6) along with cysteine scanning mutagenesis and use of impermeant and fluorescent, thiol-directed probes. Together, these tools allowed us to document residue accessibility, and therefore topology, by examining the fluorescence of purified protein.

Success in such work depends principally on use of an impermeant fluorescent probe, and for this purpose we selected OGM, a maleimide-linked reporter having both acidic hydroxyl (pK = 4.7) and carboxyl (pKa < 5) functions. The modest size (460 daltons) and the charged nature of this probe suggested it would penetrate the outer membrane of E. coli yet not permeate across the plasma membrane, a presumption supported by two kinds of observations. First, when OGM was used to treat intact cells, a cysteine (A370C) expected to be exposed externally was readily modified, while sparing an internal cysteine (A345C) (Fig. 3, experiment 1). Second (Fig. 3, experiment 2), we could also show that the external cysteine (A370C) was protected by treating cells with the impermeant quaternary amine, MTSET, without effect on subsequent OGM reactivity of the internal target (A345C).

The reactivity of variants A345C and A370C to these impermeant probes (OGM, MTSET) (Fig. 3) supports several conclusions. Clearly, these positions lie at opposite membrane surfaces, with A345C facing the cytoplasm and A370C the periplasm, as predicted by the initial analysis of hydropathy (11). It is also evident that the entire population of OxlT is of uniform topology, indicating use of this heterologous overexpression system (E. coli) has not affected overall protein organization. It may be noted that in work with the intact cells we did not vary the membrane potential, the main component of the protonmotive force at pH 8 (9). While it is feasible that this parameter may affect the kinetics of OGM labeling, it seems unlikely that this would significantly alter our main conclusions (above). Such findings therefore justify use of the same approach to determining topology for other regions of OxlT; in fact, analysis of OGM accessibility of cysteines at positions 373 and 409 confirms the predicted orientation of TM12.2 We believe this strategy may also be of a more general utility, since it is increasingly common that membrane proteins are purified by affinity methods (cf. Tamai et al. (18)). Aside from simplicity, the advantage of this approach described here is that topology is documented in the context of the whole molecule. This contrasts with more widely used genetic methods that infer topology from the disposition of reporter molecules fused to fragments of the target (e.g. see Calamia and Manoil (19)).

The main goal of this work was to use site-directed fluorescence to determine whether Lys355 is within the TM11 hydrophobic core. Study of K355C itself was not feasible, for while this variant is fully expressed, its null phenotype (Fig. 2) raises doubts concerning structure in the vicinity of position 355. Accordingly, the location of Lys355 was inferred from the behavior of functional derivatives spanning the entirety of TM11. That work (Fig. 4) revealed a striking discontinuity in OGM accessibility along TM11. Thus, when OxlT was labeled in situ, cysteines within a central 10-residue segment (residues 351-360) failed to react with OGM, while cysteines at either end gave fluorescent product (Fig. 4). There are two general explanations for such findings. One interpretation is that the region of low reactivity (positions 351-360) is within the lipid bilayer and hence unavailable to the impermeant probe, and a semiquantitative argument is consistent with this suggestion. Thus, on modification of its target, the OGM carboxylate lies about 8-10 Å from the cysteinyl sulfur. Accordingly, one expects cysteines that react with OGM to be within 8-10 Å of the external or internal aqueous phases. And if TM11 is a transmembrane alpha -helix, of the 20-25 residues that span the 30-40-Å bilayer, one expects a central core of some 10 residues (e.g. residues 351-360) to be inaccessible to OGM for purely geometric reasons. A biotin-linked maleimide of similar dimensions defines a comparable set of core residues along TM7 of UhpT, the E. coli sugar phosphate transporter (20). A second line of reasoning suggests that cysteines in this core are unreactive for reasons of chemistry, in that they display the high pKa (pKa = 14) characteristic of cysteine in a nonpolar (i.e. lipid) environment. In this second case, the reactive sulfide (-S1-) would be not be at sufficiently high concentration to support modification. One presumes this principle underlies the low N-ethylmaleimide reactivity of single-cysteine derivatives of TM9 in the tetracylcine antiporter, TetA (21). We caution, however, that such alternative explanations are not mutually exclusive. Rather, a transmembrane helix may have positions facing other helices or the hydrophilic translocation pathway (cf. Goswitz and Brooker (22)); these positions may be inaccessible, but possibly chemically reactive. Or, there may be positions facing membrane lipid, and while these may be accessible, they are most likely chemically unreactive. In either case, the finding that residues 351-360 form the core of TM11 effectively positions Lys355 at the center of the OxlT hydrophobic sector.

While the conclusion that TM11 has an inaccessible core of about 10 residues is not surprising, it is unusual that this core includes a basic residue, Lys355. As judged from examples known at a crystallographic level, transmembrane helices do not typically contain charged residues (23-28), and if they are present, it is almost always in combination with a second residue of opposite charge (24-26), a conclusion also reached during genetic and biochemical studies of the LacY symporter (29-31). Hydropathy analysis of the OxlT sequence does not suggest an anionic partner which might pair with Lys355 (11), and for this reason one should now consider the alternative hypothesis that this basic residue, by virtue of its location at the center of TM11, is strategically placed to interact directly with OxlT substrates as they enter the hydrophilic translocation pathway, much as anionic residues in the Na+/melibiose MelB symporter are thought to interact directly with the cosubstrate, Na+ (32, 33). This last possibility has further merit in that it may help explain the marked effect of oxalate on OxlT stability. Thus, substrate binding energy dramatically increases the stability of the purified protein in lipid/detergent micelles (6, 34). An attractive explanation for this phenomenon is that the anionic substrate donates a negative charge that removes an unavoidable destabilizing element contributed by the uncompensated, resident cation, Lys355.

    ACKNOWLEDGEMENTS

We thank Drs. Sriram Subramaniam and Keietsu Abe for helpful discussions.

    FOOTNOTES

* This work was supported by National Science Foundation Research Grant MCB-9603997.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Present address: Dept. of Biochemistry, University of California at San Francisco, San Francisco, CA 94143-0448.

§ To whom correspondence should be addressed: Dept. of Physiology, Johns Hopkins School of Medicine, 725 North Wolfe St., Baltimore, MD 21205-2185. Tel.: 410-955-8325; Fax: 410-955-4438; E-mail: peter_maloney{at}qmail.bs.jhmi.edu.

1 The abbreviations used are: TM, transmembrane helix; OGM, Oregon Green 488 maleimide carboxylic acid; MTSET, methanethiosulfonate etheyltrimethylammonium; PAGE, polyacrylamide gel electrophoresis; MOPS, 4-morpholinepropanesulfonic acid.

2 T. Jung and P. C. Maloney, unpublished results.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Griffith, J. K., Baker, M. E., Rouch, D. A., Page, M. G. P., Skurray, R. A., Paulsen, I. T., Chater, K. F., Baldwin, S. A., and Henderson, P. J. F. (1992) Curr. Opin. Cell Biol. 4, 684-695[Medline] [Order article via Infotrieve]
  2. Marger, S. D., and Saier, M. H., Jr. (1993) Trends Biochem. Sci. 18, 13-20[CrossRef][Medline] [Order article via Infotrieve]
  3. Maloney, P. C. (1994) Curr. Opin. Cell Biol. 6, 571-582[Medline] [Order article via Infotrieve]
  4. Clayton, R. A., White, O., Ketchum, K. A., and Venter, J. C. (1997) Nature 387, 459-4662[CrossRef][Medline] [Order article via Infotrieve]
  5. Ruan, Z.-S., Anantharam, V., Crawford, I. T., Ambudkar, S. V., Rhee, S. Y., Allison, M. J., and Maloney, P. C. (1992) J. Biol. Chem. 267, 10537-10543[Abstract/Free Full Text]
  6. Fu, D., and Maloney, P. C. (1997) J. Biol. Chem. 272, 2129-2135[Abstract/Free Full Text]
  7. Pao, S. S., Paulsen, I. T., and Saier, M. H., Jr. (1998) Microbiol. Mol. Biol. Rev. 62, 1-34[Abstract/Free Full Text]
  8. Anantharam, V., Allison, M. J., and Maloney, P. C. (1989) J. Biol. Chem. 264, 7244-7250[Abstract/Free Full Text]
  9. Harold, F. M., and Maloney, P. C. (1996) in in Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology (Neidhardt, F. C., Curtiss, R., Ingraham, J. L., Lin, E. C. C., Low, K. B., Magasanik, B., Reznikoff, W. S., Riley, M., Schaechter, M., and Umbarger, H. E., eds), pp. 283-306, American Society for Microbiology, Washington, D. C.
  10. Klenk, H.-P., Clayton, R. A., Tomb, J.-F., et al.. (1997) Nature 390, 364-370[CrossRef][Medline] [Order article via Infotrieve]
  11. Abe, K., Ruan, Zhong-Shi, and Maloney, P. C. (1996) J. Biol. Chem. 271, 6789-6793[Abstract/Free Full Text]
  12. Kyte, J., and Doolittle, R. F. (1982) J. Mol. Biol. 157, 105-132[Medline] [Order article via Infotrieve]
  13. Engleman, D. M., Steitz, T. A., and Goldman, A. (1986) Annu. Rev. Biophys. Biophys. Chem. 15, 321-353[CrossRef][Medline] [Order article via Infotrieve]
  14. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467[Abstract]
  15. Varadhachary, A., and Maloney, P. C. (1990) Mol. Microbiol. 4, 1407-1411[Medline] [Order article via Infotrieve]
  16. Schaffner, W., and Weissman, C. (1973) Anal. Biochem. 56, 502-514[Medline] [Order article via Infotrieve]
  17. Yan, R.-T., and Maloney, P. C. (1993) Cell 75, 37-44[Medline] [Order article via Infotrieve]
  18. Tamai, E., Fann, F.-C., Tsuchiya, T., and Maloney, P. C. (1997) Protein Expr. Purif. 10, 275-282[CrossRef][Medline] [Order article via Infotrieve]
  19. Calamia, J., and Manoil, C. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4937-4941[Abstract]
  20. Matos, M., Fann, M.-C., Yan, R.-T., and Maloney, P. C. (1996) J. Biol. Chem. 271, 18571-19575[Abstract/Free Full Text]
  21. Kimura, T., Suzuki, M., Sawai, T., and Yamaguchi, A. (1996) Biochemistry 35, 15896-15899[CrossRef][Medline] [Order article via Infotrieve]
  22. Goswitz, V. C., and Brooker, R. J. (1995) Protein Sci. 4, 534-537[Abstract/Free Full Text]
  23. Deisenhofer, J., and Michael, H. (1989) EMBO J. 8, 2149-2169[Abstract]
  24. Kuhlbrandt, W., Wang, D. N., and Fujiyoshi, Y. (1994) Nature 367, 614-621[CrossRef][Medline] [Order article via Infotrieve]
  25. Iwata, S., Ostermeier, C., Ludwig, B., and Michel, H. (1995) Nature 376, 660-669[CrossRef][Medline] [Order article via Infotrieve]
  26. Grigorieff, N., Ceska, T. A., Downing, K. H., Baldwin, J. M., and Henderson, R. (1996) J. Mol. Biol. 259, 393-421[CrossRef][Medline] [Order article via Infotrieve]
  27. Tsukihara, T., Aoyaa, H., Yamashita, E., Tomizaki, T., Yamaguchi, H., Shinzawa-Itoh, K., Nakashima, R., Yaono, R., and Yoshikawa, S. (1996) Science 272, 1136-1144[Abstract]
  28. Xia, D., Yu, C. A., Kim, H., Xia, J. Z., Kachurin, A. M., Zhang, L., Yu, L., and Deisenhofer, J. (1997) Science 277, 60-66[Abstract/Free Full Text]
  29. King, S. C., Hansen, C. L., and Wilson, T. H. (1991) Biochim. Biophys. Acta 1062, 177-186[Medline] [Order article via Infotrieve]
  30. Lee, J.-I., Hwant, P. P., and Wilson, T. H. (1993) J. Biol. Chem. 268, 20007-20015[Abstract/Free Full Text]
  31. Dunten, R. L., Sahin-Toth, M., and Kaback, H. R. (1993) Biochemistry 32, 3139-3145[Medline] [Order article via Infotrieve]
  32. Pourcher, T., M. L., Zani, and Leblanc, G. (1993) J. Biol. Chem. 268, 3209-3215[Abstract/Free Full Text]
  33. Hama, H., and Wilson, T. H. (1994) J. Biol. Chem. 269, 1063-1067[Abstract/Free Full Text]
  34. Maloney, P. C., Anantharam, V., and Allison, M. J. (1992) J. Biol. Chem. 267, 10531-10536[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.